Bestselling Author and Food Revolution Network President John Robbins Has Passed Away

A Pioneer Who Changed the Way the World Thinks About Food Leaves a Lasting Legacy SANTA…

RCKT INVESTOR ALERT: Robbins Geller Rudman & Dowd Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO–(BUSINESS WIRE)–The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or…

HSS Study at EULAR 2025 Congress Uses an AI Model to Predict Readmissions of Pregnant Women with Lupus Based on Social Determinants of Health

BARCELONA, Spain–(BUSINESS WIRE)–Hospital for Special Surgery (HSS) presented a research study at the European Alliance of…

Mogo Applies to Extend the Expiry Dates of Certain Warrants

VANCOUVER, British Columbia–(BUSINESS WIRE)–Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) (“Mogo” or the “Company”), a digital wealth and payments…

Prime Success Responds to Sinovac Biotech’s False and Misleading Claims

For More Information, Visit www.SaveSinovac.com HONG KONG–(BUSINESS WIRE)–Prime Success L.P., (together with its affiliates, “Prime Success”…

When Golden Sunflower Meets Bauhinia: HONGQI Showcases Oriental Luxury at 2025 International Automotive and Supply Chain Expo(Hong Kong)

CHANGCHUN, China–(BUSINESS WIRE)–From June 12 to 15, FAW HONGQI unveiled its luxury vehicle lineup at the…

Specialities Inc. Introduces Hollandic

MILLINGTON, N.J.–(BUSINESS WIRE)–Hollandic is how we say Gouda cheese! We are thrilled to introduce Hollandic, our…

WhiteHawk Capital Partners Announces $70 Million Senior Secured Term Loan to a Leading Operator in the Food Distribution and Logistics Sector

  LOS ANGELES–(BUSINESS WIRE)–WhiteHawk Capital Partners: WhiteHawk Capital Partners has provided a $70 million senior secured…

Public Sector Application Risk Accumulates as Security Debt Grows Across Government Systems

Veracode’s Public Sector State of Software Security 2025 Report Reveals 78% of Government Organizations Operate with…

Capsida Receives FDA IND Clearance for Its IV-Administered Gene Therapy for Parkinson’s Disease Associated With GBA Mutations

Capsida is initiating the Phase 1/2 study for CAP-003, with the first patient expected to be…